Abbreviations |
|
xii | |
|
|
1 | (12) |
|
|
1 | (2) |
|
1.2 The theory of evolution by natural selection |
|
|
3 | (4) |
|
1.3 The different conceptual bases of medicine and evolutionary biology |
|
|
7 | (4) |
|
1.4 Why our evolutionary heritage has left us vulnerable to disease |
|
|
11 | (2) |
|
2 Human demography, history, and disease |
|
|
13 | (16) |
|
|
13 | (1) |
|
2.2 Population growth: birth rates and death rates |
|
|
13 | (2) |
|
2.3 Population growth in age-structured populations: fertility rates |
|
|
15 | (4) |
|
2.4 Age-specific death rates |
|
|
19 | (2) |
|
2.5 History of human population growth |
|
|
21 | (5) |
|
2.6 The future of the human population |
|
|
26 | (3) |
|
|
29 | (14) |
|
|
29 | (1) |
|
3.2 Other evolutionary processes: mutation, genetic drift, and migration |
|
|
30 | (3) |
|
|
33 | (1) |
|
3.4 Heterozygote advantage |
|
|
34 | (1) |
|
3.5 Pleiotropy and epistasis |
|
|
35 | (1) |
|
3.6 Linkage and hitchhiking |
|
|
36 | (1) |
|
3.7 Frequency dependent selection |
|
|
36 | (1) |
|
3.8 Epigenetic regulation of gene expression |
|
|
37 | (1) |
|
3.9 Population structure and mating patterns |
|
|
38 | (1) |
|
3.10 Genetic consequences of human evolutionary history |
|
|
39 | (1) |
|
3.11 Natural selection in human populations |
|
|
40 | (3) |
|
|
43 | (8) |
|
|
43 | (2) |
|
4.2 CFTR, the cystic fibrosis transmembrane conductance regulator |
|
|
45 | (1) |
|
4.3 Genotypic diversity and phenotypic heterogeneity in cystic fibrosis |
|
|
46 | (1) |
|
4.4 Relationship between genotype and phenotype |
|
|
47 | (1) |
|
4.5 Evolution of mutant CFTR alleles |
|
|
48 | (3) |
|
5 Life history tradeoffs and the evolutionary biology of aging |
|
|
51 | (14) |
|
|
51 | (2) |
|
5.2 The causes of death change through the life cycle |
|
|
53 | (1) |
|
|
54 | (1) |
|
5.4 The life history theory of aging |
|
|
55 | (2) |
|
5.5 Genetic causes of aging |
|
|
57 | (1) |
|
5.6 Proximate causes of aging |
|
|
58 | (1) |
|
5.7 Somatic repair and the depletion of physiological capital |
|
|
59 | (2) |
|
5.8 Plasticity in rates of aging |
|
|
61 | (1) |
|
5.9 Developmental origins of health and disease |
|
|
62 | (3) |
|
|
65 | (12) |
|
|
65 | (1) |
|
6.2 Cancer as a disease of aging |
|
|
65 | (1) |
|
6.3 Regulation of cell growth and replication |
|
|
66 | (3) |
|
6.4 Selection for cells that escape normal growth controls |
|
|
69 | (2) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
73 | (1) |
|
6.8 Carcinogenesis and cancer prevention |
|
|
74 | (3) |
|
7 Host-pathogen coevolution |
|
|
77 | (14) |
|
|
77 | (1) |
|
7.2 Epidemiology of pathogen transmission |
|
|
78 | (2) |
|
7.3 Virulence and transmissibility |
|
|
80 | (1) |
|
7.4 Host-pathogen coevolution: hosts evolve in ways that minimize the fitness cost of pathogens |
|
|
81 | (1) |
|
7.5 Host-pathogen coevolution: pathogens evolve in ways that optimize their fitness |
|
|
82 | (2) |
|
7.6 Myxomatosis: a case study of host-pathogen coevolution |
|
|
84 | (1) |
|
7.7 Complexities in host-pathogen interactions |
|
|
85 | (2) |
|
7.8 Antibiotic resistance: methicillin-resistant Staphylococcus aureus |
|
|
87 | (3) |
|
7.9 Manifestations of disease |
|
|
90 | (1) |
|
8 Sexually transmitted diseases |
|
|
91 | (12) |
|
|
91 | (1) |
|
8.2 The epidemiology of sexually transmitted diseases |
|
|
92 | (2) |
|
8.3 Evolutionary responses of hosts to sexually transmitted pathogens |
|
|
94 | (1) |
|
|
95 | (3) |
|
|
98 | (5) |
|
|
103 | (12) |
|
|
103 | (1) |
|
9.2 The life history of Plasmodium falciparum |
|
|
103 | (3) |
|
9.3 The natural history of malaria infections |
|
|
106 | (2) |
|
9.4 Ro, the basic reproductive number of P. falciparum |
|
|
108 | (1) |
|
9.5 Virulence of P. falciparum |
|
|
109 | (1) |
|
9.6 Evolution of P. falciparum and other malaria parasites |
|
|
110 | (1) |
|
9.7 Mosquitoes that transmit P. falciparum |
|
|
111 | (1) |
|
9.8 Effects of malaria on human evolution |
|
|
112 | (2) |
|
9.9 The future of malaria |
|
|
114 | (1) |
|
10 Gene-culture coevolution: lactase persistence |
|
|
115 | (12) |
|
|
115 | (1) |
|
|
116 | (1) |
|
10.3 A brief history of animal domestication and dairying |
|
|
117 | (1) |
|
10.4 The evolution of lactose synthesis and metabolism |
|
|
118 | (2) |
|
10.5 Lactase restriction and lactase persistence |
|
|
120 | (2) |
|
10.6 The coevolution of lactase persistence and dairying |
|
|
122 | (5) |
|
|
127 | (16) |
|
|
127 | (1) |
|
11.2 Diet, obesity, and diabetes |
|
|
128 | (3) |
|
11.3 Salt intake and hypertension |
|
|
131 | (3) |
|
11.4 Elimination of old pathogens: the hygiene hypothesis |
|
|
134 | (3) |
|
11.5 Hierarchical societies and socioeconomic disparities in health |
|
|
137 | (4) |
|
11.6 Reducing the burden of man-made diseases |
|
|
141 | (2) |
Glossary |
|
143 | (2) |
References |
|
145 | (14) |
Index |
|
159 | |